The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.

The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.

Systemic lupus erythematosus (SLE) is a complex, systemic autoimmune disease with a diverse range of immunological and clinical manifestations. The introduction of broad spectrum immunosuppressive therapies and better management of acute disease exacerbations have improved outcomes for lupus patient...

Full description

Bibliographic Details
Main Authors:	Yuan Liu, Josephine Ye, Luisa Shin Ogawa, Takayo Inoue, Qin Huang, John Chu, Richard C Bates, Weiwen Ying, Andrew J Sonderfan, Patricia E Rao, Dan Zhou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0127361

Similar Items

Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancer.
by: Cheryl A London, et al.
Published: (2011-01-01)

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
by: Roberto Gomez-Casal, et al.
Published: (2015-05-01)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
by: Maria Gulinello, et al.
Published: (2011-01-01)

Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
by: Rui Yuan, et al.
Published: (2021-05-01)

The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice
by: Hong LJ, et al.
Published: (2020-10-01)

Prolactin Levels Correlate with Abnormal B Cell Maturation in MRL and MRL/lpr Mouse Models of Systemic Lupus Erythematosus-Like Disease
by: Maria Victoria Legorreta-Haquet, et al.
Published: (2013-01-01)

Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling.
by: David A Proia, et al.
Published: (2011-01-01)

An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein
by: Jessica McCready, et al.
Published: (2014-04-01)

Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr Mice
by: Jiali Zhu, et al.
Published: (2014-01-01)

Immunomodulation of Longdan-Xiegan-Tang on CD4+CD25+ T Cell in MRL lpr/lpr Mice
by: Fang Yu Chen, et al.
Published: (2009)

The Immunological Modulated Effects of Longdan Xiegan Tang on Systemic Lupus Erythematousus of MRL lpr/lpr Mice
by: Wen Tsung Kai, et al.
Published: (2006)

Detection of anti-neutrophil cytoplasmic antibodies in MRL/Mp-lpr/lpr mice and analysis of their target antigens
by: Ma, Wei
Published: (2011)

ALW peptide ameliorates lupus nephritis in MRL/lpr mice
by: Huixia Wang, et al.
Published: (2019-12-01)

Cellular abnormalities seen in the autoimmune MRL-lpr mouse strain
by: Kaminski, Debra Ann
Published: (2010)

Regulating T Cell Population Alleviates SLE by Inhibiting mTORC1/C2 in MRL/lpr Mice
by: Dongya Zhang, et al.
Published: (2021-01-01)

Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice
by: Seung-Min Hong, et al.
Published: (2020-11-01)

Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice
by: Maira Soto, et al.
Published: (2020-07-01)

The Protective Effects of Ultraviolet A1 Irradiation on Spontaneous Lupus Erythematosus-Like Skin Lesions in MRL/lpr Mice
by: Naoya Mikita, et al.
Published: (2009-01-01)

Activity of the heat shock protein 90 inhibitor ganetespib in melanoma.
by: Xinqi Wu, et al.
Published: (2013-01-01)

Beneficial Effect of Bupleurum Polysaccharides on Autoimmune-Prone MRL-lpr Mice
by: Yi-Wen Jiang, et al.
Published: (2012-01-01)

HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma
by: Guan L, et al.
Published: (2020-04-01)

Study on ameliorative effects of the ethyl acetate extract of alfalfa sprouts on disease course of MRL-lpr/lpr autoimmune-prone mice
by: Yong-Han Hong, et al.
Published: (2008)

Complement Properdin Determines Disease Activity in MRL/<i>lpr</i> Mice
by: Hasanain Alaridhee, et al.
Published: (2020-08-01)

The effect of yam feeding on the disease severity of autoimmune prone MRL/lpr mice
by: I-Ten Hong, et al.
Published: (2007)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
by: Min Ye, et al.
Published: (2021-07-01)

Die späte Blockade von CCR1 mit BX471 verbessert die Lupusnephritis bei MRL lpr/lpr Mäusen
by: Belemezova, Emilia
Published: (2006)

Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.
by: Qingran Yan, et al.
Published: (2014-01-01)

Defects in the peripheral taste structure and function in the MRL/lpr mouse model of autoimmune disease.
by: Agnes Kim, et al.
Published: (2012-01-01)

Alterations of the Gut Microbiota Associated With Promoting Efficacy of Prednisone by Bromofuranone in MRL/lpr Mice
by: Zhixing He, et al.
Published: (2019-05-01)

The in vivo and in vitro effects of diethyldithiocarbamate on autoimmune New Zealand Black/White F₁ hybrid, MRL/Mp-lpr/lpr and related and normal murine strains.
by: Halpern, Melissa Dale.
Published: (1989)

Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
by: Takashi Izawa, et al.
Published: (2012-01-01)

IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/<it>lpr </it>mice
by: Greenspan Neil S, et al.
Published: (2012-01-01)

Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice
by: Yinglu Feng, et al.
Published: (2015-01-01)

Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice
by: Mingzhu Wang, et al.
Published: (2021-09-01)

Ganetespib: research and clinical development
by: Jhaveri K, et al.
Published: (2015-07-01)

The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer
by: Christopher E. Eyermann, et al.
Published: (2021-01-01)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
by: Yu Shi, et al.
Published: (2019-11-01)

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
by: Fleur Schaper, et al.
Published: (2016-01-01)

Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1
by: Weidong Xu, et al.
Published: (2019-06-01)

Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
by: Xiaofeng Liao, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_tnnfdn9051volj8b2nod1cvhi3